Olmesartan Reference Standards & Impurities | Simson Pharma Private Limited

Olmesartan Related Compounds & Impurities

Olmesartan is an angiotensin II AT1 receptor blocker (ARB) with potent and sustained blood pressure-lowering effects.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Olmesartan reference standards, pharmacopeial and non-pharmacopeial Olmesartan impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Olmesartan-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

1,4-Dichloropentane

CAT. No.O020059 CAS No.626-92-6 Mol. F.C5H10Cl2 Mol. W.141.04 g/mol Stock Status Custom Synthesis

COA MSDS

1H-Imidazole-5-carboxylic acid, 4-acetyl-2-propyl-1-[[2`-(2H-tetrazol-5-yl)[1,1`-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester

CAT. No.O020099 CAS No.1227626-44-9 Mol. F.C28H26N6O6 Mol. W.542.54 g/mol Stock Status Custom Synthesis

COA MSDS

Search products

Olmesartan Related Compounds & Impurities

Impurity Standards

1,4-Dichloropentane

1H-Imidazole-5-carboxylic acid, 4-acetyl-2-propyl-1-[[2`-(2H-tetrazol-5-yl)[1,1`-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester

2,2'-methylenedianiline

2,3-dichlorohexane

2-Carboxyquinone

2-Propylbenzimidazole

3-Chloro-2-butanone

4,5-bis(hydroxymethyl)-1,3-dioxolan-2-one

4-(bromomethyl)-5-methyl-1,3-dioxol-2-one

5-(4-Hydroxymethyl-1,1-biphenyl-2-yl)-1-triphenylmethyl-1H-tetrazole

6,6-dimethyl-2-propyl-3,6-dihydro-4H-furo[3,4-d]imidazol-4-one

Cyano diazide

Dehydro Olmesartan Impurity

Dehydro Olmesartan-2-trityl Medoxomil

Dimethylvinylene Carbonate

Ethyl Olmesartan Medoxomil

ethyl-2-ethyl-4-(2-hydroxypropan-2-yl)-1H-imidazole-5-carboxylate

Ethyl5-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-4-carboxylate

N,N`-Dibromodimethylhydantoin)

N-(1,3-dioxoisoindolin-4-yl)acetamide

N-alkylated olmesartan medoxomil

N-Nitroso Imidazole Ester Olmesartan

N-Nitroso Olmesartan

N-Nitroso Olmesartan Impurity

Product structure

Sample structure